SARL Armen Instrument has sold the flash chromatography division to Interchim SA
SARL Armen Instrument has sold its flash chromatography branch of activity to Interchim SA. Financial terms of this transaction have not been disclosed.
This sale will enable Armen Instrument to focus on its core businesses of developing and marketing preparative high-performance chromatography machines with modular and integrated systems, as well as centrifuge partition chromatography and CPC/CCC solutions. Francois Couillard, founder of the company, said: "Armen Instrument's experience in liquid chromatography has culminated in this sale of its flash chromatography business to its strategic partner, Interchim SA. The expertise developed over more than five years of flash chromatography R&D work and the marketing of machines like the SPOT II has been acknowledged by a world-renowned company."
Oaklins' team in France advised the seller in this transaction.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn moreNiscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn more